Home Healthcare Medical Devices Pulmonary Drug Delivery Systems Market

Pulmonary Drug Delivery Systems Market Size, Share & Trends Analysis Report By Product (Inhalers, Nebulizers, Jet Nebulizers, Soft-Mist Nebulizers, Ultrasonic Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Rhinitis, Pulmonary Arterial Hypertension, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Pulmonary Drug Delivery Systems Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Inhalers
    2. Nebulizers
    3. Jet Nebulizers
    4. Soft-Mist Nebulizers
    5. Ultrasonic Nebulizers
  2. Pulmonary Drug Delivery Systems Market, By Application  2022-2034 (USD MILLION/ Units)
    1. Asthma
    2. Chronic Obstructive Pulmonary Disease (COPD)
    3. Allergic Rhinitis
    4. Pulmonary Arterial Hypertension
    5. Others
  3. Pulmonary Drug Delivery Systems Market, By End Use 2022-2034 (USD MILLION/ Units)
    1. Hospitals & Clinics
    2. Ambulatory Surgical Centers
    3. Homecare Settings
    4. Others
  4. Regional Pulmonary Drug Delivery Systems Market
    1. North America
      1. North America Pulmonary Drug Delivery Systems Market By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
      2. North America Pulmonary Drug Delivery Systems Market By Application  2022-2034 (USD MILLION/ Units)
        1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Allergic Rhinitis
        4. Pulmonary Arterial Hypertension
        5. Others
      3. North America Pulmonary Drug Delivery Systems Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Others
      4. U.S.
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      5. Canada
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
    2. Europe
      1. Europe Pulmonary Drug Delivery Systems Market By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
      2. Europe Pulmonary Drug Delivery Systems Market By Application  2022-2034 (USD MILLION/ Units)
        1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Allergic Rhinitis
        4. Pulmonary Arterial Hypertension
        5. Others
      3. Europe Pulmonary Drug Delivery Systems Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Others
      4. U.K.
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      5. Germany
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      6. France
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      7. Spain
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      8. Italy
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      9. Russia
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      10. Nordic
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      11. Benelux
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      12. Rest of Europe
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
    3. APAC
      1. APAC Pulmonary Drug Delivery Systems Market By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
      2. APAC Pulmonary Drug Delivery Systems Market By Application  2022-2034 (USD MILLION/ Units)
        1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Allergic Rhinitis
        4. Pulmonary Arterial Hypertension
        5. Others
      3. APAC Pulmonary Drug Delivery Systems Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Others
      4. China
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      5. Korea
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      6. Japan
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      7. India
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      8. Australia
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      9. Taiwan
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      10. South East Asia
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      11. Rest of Asia-Pacific
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Pulmonary Drug Delivery Systems Market By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
      2. Middle East and Africa Pulmonary Drug Delivery Systems Market By Application  2022-2034 (USD MILLION/ Units)
        1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Allergic Rhinitis
        4. Pulmonary Arterial Hypertension
        5. Others
      3. Middle East and Africa Pulmonary Drug Delivery Systems Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Others
      4. UAE
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      5. Turkey
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      6. Saudi Arabia
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      7. South Africa
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      8. Egypt
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      9. Nigeria
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      10. Rest of MEA
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
    5. LATAM
      1. LATAM Pulmonary Drug Delivery Systems Market By Product 2022-2034 (USD MILLION/ Units)
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
      2. LATAM Pulmonary Drug Delivery Systems Market By Application  2022-2034 (USD MILLION/ Units)
        1. Asthma
        2. Chronic Obstructive Pulmonary Disease (COPD)
        3. Allergic Rhinitis
        4. Pulmonary Arterial Hypertension
        5. Others
      3. LATAM Pulmonary Drug Delivery Systems Market By End Use 2022-2034 (USD MILLION/ Units)
        1. Hospitals & Clinics
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Others
      4. Brazil
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      5. Mexico
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      6. Argentina
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      7. Chile
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      8. Colombia
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
      9. Rest of LATAM
        1. Inhalers
        2. Nebulizers
        3. Jet Nebulizers
        4. Soft-Mist Nebulizers
        5. Ultrasonic Nebulizers
        6. Asthma
        7. Chronic Obstructive Pulmonary Disease (COPD)
        8. Allergic Rhinitis
        9. Pulmonary Arterial Hypertension
        10. Others
        11. Hospitals & Clinics
        12. Ambulatory Surgical Centers
        13. Homecare Settings
        14. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.